Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
about
Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progressionCombination of 247 genome-wide association studies reveals high cancer risk as a result of evolutionary adaptation.
P2860
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
@en
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
@nl
type
label
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
@en
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
@nl
prefLabel
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
@en
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer
@en
P2093
Amir Sapkota
Anna Shestakova
Bhola Siwakoti
Binay Kumar Thakur
Bing-Jian Feng
Chad D Huff
Chin Bahadur Pun
Josef T Prchal
Mia Hashibe
P2860
P304
11739-11747
P356
10.18632/ONCOTARGET.14340
P407
P577
2017-02-01T00:00:00Z